AXSM
AXSM
NASDAQ · Pharmaceuticals

Axsome Therapeutics Inc

$207.78
-6.50 (-3.03%)
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 26 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -68.2% upside
Low Target $47.60
Average Target $66.03
High Target $88.20
Current Price $207.78
Current
$207.78
Target
$66.03
$47.60 $66.03 avg $88.20
Scenario Analysis
Bear Case
$47.60
-77.1%
Low target
Base Case
$66.03
-68.2%
Avg target
Bull Case
$88.20
+-57.6%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$260.19
-20.1% from high
52-Week Low
$113.85
+82.5% from low
50-Day SMA
$171.07
+21.5% vs SMA
200-Day SMA
$131.37
+58.2% vs SMA
RSI (14)
51.8
Neutral
Target vs 52W High
$66.03
-74.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.0%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +10.5%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.1%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.5%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +177.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.9%